diallyl disulfide has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arditti, FD; Berrebi, A; Miron, T; Shvidel, L; Wilchek, M | 1 |
1 other study(ies) available for diallyl disulfide and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
S-allyl derivatives of 6-mercaptopurine are highly potent drugs against human B-CLL through synergism between 6-mercaptopurine and allicin.
Topics: Allyl Compounds; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; B-Lymphocytes; Cell Membrane Permeability; Disease Models, Animal; Disulfides; DNA; Drug Synergism; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mercaptopurine; Mice; Mice, Inbred ICR; Oxidation-Reduction; Prodrugs; Sulfhydryl Compounds; Sulfinic Acids | 2012 |